JP Morgan Maintains Neutral on Okta, Raises Price Target to $245
JP Morgan analyst Sterling Auty maintains Okta (NASDAQ:OKTA) with a Neutral and raises the price target from $235 to $245.
Earnings Scheduled For May 26, 2021
Companies Reporting Before The Bell
• Boqii Holding (NYSE:BQ) is expected to report quarterly loss at $0.14 per share on revenue of $35.05 million.
Stifel Initiates Coverage On Okta with Hold Rating, Announces Price Target of $260
Stifel analyst Adam Borg initiates coverage on Okta (NASDAQ:OKTA) with a Hold rating and announces Price Target of $260.
Cathie Wood’s ARK Invest Posts Fund Purchases For Thursday, Apr. 22, 2021: RXRX, MASS, IONS, SKLZ, IRDM, DKNG, COIN, BEAM, SPFR, NIU, DDD, PDD, OKTA, TCEHY
Recursion Pharmaceuticals (RXRX) - 11,311 Shares
908 Devices (MASS) - 3,616
Ionis Pharmaceuticals (IONS) - 18,496
Skillz (SKLZ) - 1,222,207
Iridium Communications (IRDM) - 112,519
DraftKings (DKNG) -
Cathie Wood Loads Up On DraftKings, Coinbase, Palantir, Sells Nvidia, Square
Cathie Wood-led Ark Investment Management on Tuesday snapped up another 236,348 shares of cryptocurrency exchange Coinbase Global Inc (NASDAQ: COIN).
Cathie Wood’s ARK Invest Posts Fund Purchases For Tuesday, Apr. 20, 2021: JD, OPEN, PDD, RXRX, IONS, PLTR, DKNG, COIN, BLI, BEAM, TSP, WKHS, SPFR, NIU, IRDM, DDD, TCEHY, RBLX, PTON, OKTA, RTP
JD.Com (JD) - 88,313 Shares
Opendoor Technologies (OPEN) - 137,988
Pinduoduo (PDD) - 33,037
Recursion Pharmaceuticals (RXRX) - 5,254
Ionis Pharmaceuticals (IONS) - 90,284
Palantir Technologies (PLTR) -